Ikena Oncology (IKNA) Earnings Date & Reports

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IKNA is expected to report earnings to fall 4.05% to -19 cents per share on May 08

Ikena Oncology IKNA Stock Earnings Reports

Q1'25

Est.

$-0.19

Q4'24

Beat

by $0.01

Q3'24

Beat

by $0.04

Q2'24

Beat

by $0.08

Q1'24

Beat

by $0.07

The last earnings report on March 06 showed earnings per share of -20 cents, beating the estimate of -20 cents. With 28.36K shares outstanding, the current market capitalization sits at 57.91M.

View a ticker or compare two or three

Compare

IKNA